Dow Down 0.18% Nasdaq Up 0.39%

Infinity Pharmaceuticals, Inc. (INFI)

-NasdaqGS
10.92 Down 0.38(3.36%) 4:00PM EDT
Prev Close:11.30
Open:11.40
Bid:9.30 x 2000
Ask:13.00 x 800
1y Target Est:15.56
Beta:1.67
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:10.85 - 11.41
52wk Range:8.40 - 21.60
Volume:272,124
Avg Vol (3m):510,102
Market Cap:530.56M
P/E (ttm):N/A
EPS (ttm):-2.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INFI

Comparison

Symbol% ChgMkt Cap
INFIDown 3.36%530.56M
BMYDown 0.14%83.86B
PFEDown 0.44%185.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.48
Quarterly EPS Est (Sep-14) :-0.88
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-1.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Infinity Pharmaceuticals, Inc., a drug discovery and development company, focuses on discovering, developing, and delivering medicines to people with difficult-to-treat diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback